We asked Chat GPT-4 to analyze sources and data across the entire internet for what it thought are the most undervalued stocks in 2023. Here are A.I.’s answers: Albertsons (ACI), Alphabet (GOOGL), ASML Holding (ASML), AvalonBay...
Latest articles
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Vertex Pharmaceuticals (VRTX) is already a rock star in the world of cystic fibrosis (CF) treatment. The company's drugs have been life-changing for children and adults living with the disease. And that's resulted in...
The Highest Dividend Yields Today
This month's list of top dividend stocks consists of international marine shipping companies Frontline PLC (FRO), Genco Shipping & Trading Ltd. (GNK); energy company Berry Corp. (BRY); and real estate investment trusts Two...
Palantir (PLTR) Stock Pops Ahead of Earnings
Palantir (PLTR) stock is climbing ahead of the company’s first-quarter earnings report. The company will release its Q1 results after markets close today. Wall Street is looking for EPS of 4 cents on revenue of $504.8...
How to Prepare Your Retirement Portfolio for a Recession
The current U.S. economic expansion is now the second longest in history. While the next recession may not be imminent, at some point one will happen. So let's take a look at how to prepare your portfolio for a recession...
Advanced Micro Devices Bullish Reversal Is Still In Play
Advanced Micro Devices (NASDAQ: AMD) share prices imploded following the Q1 release, but it is not the bearish move it might otherwise be. The move is driven by the guidance, which is tepid and potentially cautious given the...
This Industrial REIT Is Putting Its Money Where Its Mouth Is
Prologis (PLD) has seen its stock decline a huge 25% or so since hitting a high-water mark in 2022. There are a lot of factors that led to the price spike and the subsequent price decline, but there's one factor that investors...
2 Things About AbbVie That Investors Are Ignoring
Investors were ready for declines in AbbVie‘s (ABBV) blockbuster immunology drug Humira. The product now is facing competition in the U.S. So, seeing a 26% drop in Humira's U.S. first-quarter sales wasn't a surprise. And...
Grab a Quick Profit off the Fed’s Last Rate Hike – Here’s How
With the Federal Reserve likely to announce its final rate hike later this week, bond trading volatility will likely subside, and trading will increase. That will make it easier to trade fixed-income spreads and easier to trade...
This Profitable Fintech Stock Trades at a Discount
This rising interest rate environment the U.S. finds itself in has made turning a profit very difficult for fintech specialists in the consumer finance space. Examples of this can be found at companies like Upstart, SoFi...